Παραπομπή APA

Varikuti, S., Volpedo, G., Saljoughian, N., Hamza, O. M., Halsey, G., Ryan, N. M., . . . Satoskar, A. R. (2019). The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani. J Infect Dis.

Παραπομπή Chicago Style

Varikuti, Sanjay, et al. "The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused By Leishmania Donovani." J Infect Dis 2019.

Παραπομπή MLA

Varikuti, Sanjay, et al. "The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused By Leishmania Donovani." J Infect Dis 2019.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.